Life Science Software Market Size, Share, and Trends 2026 to 2035

Life Science Software Market (By Deployment: Cloud, On-premise; By Application: Preclinical and Clinical Trials, Supply chain management, Research and Development, Commercial Engagement and Branding, Pharmacovigilance, Regulatory Compliance; By End-user: Biotechnology and Pharmaceutical Companies, Medical Research Centers, Medical Device Companies,) - Global Industry Analysis, Size, Trends, Leading Companies, Regional Outlook, and Forecast 2026 to 2035

Last Updated : 06 Feb 2026  |  Report Code : 7604  |  Category : ICT   |  Format : PDF / PPT / Excel

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Life Science Software Market 

5.1. COVID-19 Landscape: Life Science Software Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Life Science Software Market, By Deployment

8.1. Life Science Software Market, by Deployment

8.1.1 Cloud

8.1.1.1. Market Revenue and Forecast

8.1.2. On-premise

8.1.2.1. Market Revenue and Forecast

Chapter 9. Global Life Science Software Market, By Application

9.1. Life Science Software Market, by Application

9.1.1. Preclinical and Clinical Trials

9.1.1.1. Market Revenue and Forecast

9.1.2. Supply chain management

9.1.2.1. Market Revenue and Forecast

9.1.3. Research and Development

9.1.3.1. Market Revenue and Forecast

9.1.4. Commercial Engagement and Branding

9.1.4.1. Market Revenue and Forecast

9.1.5. Pharmacovigilance

9.1.5.1. Market Revenue and Forecast

9.1.6. Regulatory Compliance

9.1.6.1. Market Revenue and Forecast  

Chapter 10. Global Life Science Software Market, By End-user

10.1. Life Science Software Market, by End-user

10.1.1. Biotechnology and Pharmaceutical Companies

10.1.1.1. Market Revenue and Forecast

10.1.2. Medical Research Centers

10.1.2.1. Market Revenue and Forecast

10.1.3. Medical Device Companies

10.1.3.1. Market Revenue and Forecast

10.1.4. Others (Genomics and others)

10.1.4.1. Market Revenue and Forecast

Chapter 11. Global Life Science Software Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Deployment

11.1.2. Market Revenue and Forecast, by Application

11.1.3. Market Revenue and Forecast, by End-user

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Deployment

11.1.4.2. Market Revenue and Forecast, by Application

11.1.4.3. Market Revenue and Forecast, by End-user

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Deployment

11.1.5.2. Market Revenue and Forecast, by Application

11.1.5.3. Market Revenue and Forecast, by End-user

11.2. Europe

11.2.1. Market Revenue and Forecast, by Deployment

11.2.2. Market Revenue and Forecast, by Application

11.2.3. Market Revenue and Forecast, by End-user

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Deployment

11.2.4.2. Market Revenue and Forecast, by Application

11.2.4.3. Market Revenue and Forecast, by End-user

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Deployment

11.2.5.2. Market Revenue and Forecast, by Application

11.2.5.3. Market Revenue and Forecast, by End-user

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Deployment

11.2.6.2. Market Revenue and Forecast, by Application

11.2.6.3. Market Revenue and Forecast, by End-user

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Deployment

11.2.7.2. Market Revenue and Forecast, by Application

11.2.7.3. Market Revenue and Forecast, by End-user

11.3. APAC

11.3.1. Market Revenue and Forecast, by Deployment

11.3.2. Market Revenue and Forecast, by Application

11.3.3. Market Revenue and Forecast, by End-user

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Deployment

11.3.4.2. Market Revenue and Forecast, by Application

11.3.4.3. Market Revenue and Forecast, by End-user

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Deployment

11.3.5.2. Market Revenue and Forecast, by Application

11.3.5.3. Market Revenue and Forecast, by End-user

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Deployment

11.3.6.2. Market Revenue and Forecast, by Application

11.3.6.3. Market Revenue and Forecast, by End-user

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Deployment

11.3.7.2. Market Revenue and Forecast, by Application

11.3.7.3. Market Revenue and Forecast, by End-user

11.4. MEA

11.4.1. Market Revenue and Forecast, by Deployment

11.4.2. Market Revenue and Forecast, by Application

11.4.3. Market Revenue and Forecast, by End-user

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Deployment

11.4.4.2. Market Revenue and Forecast, by Application

11.4.4.3. Market Revenue and Forecast, by End-user

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Deployment

11.4.5.2. Market Revenue and Forecast, by Application

11.4.5.3. Market Revenue and Forecast, by End-user

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Deployment

11.4.6.2. Market Revenue and Forecast, by Application

11.4.6.3. Market Revenue and Forecast, by End-user

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Deployment

11.4.7.2. Market Revenue and Forecast, by Application

11.4.7.3. Market Revenue and Forecast, by End-user

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Deployment

11.5.2. Market Revenue and Forecast, by Application

11.5.3. Market Revenue and Forecast, by End-user

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Deployment

11.5.4.2. Market Revenue and Forecast, by Application

11.5.4.3. Market Revenue and Forecast, by End-user

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Deployment

11.5.5.2. Market Revenue and Forecast, by Application

11.5.5.3. Market Revenue and Forecast, by End-user

Chapter 12. Company Profiles

12.1. Oracle

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. IQVIA Inc.

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Microsoft

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Veeva Systems

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. CEGEDIM GROUP

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Optum, Inc.

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. IBM

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. SAP SE

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Salesforce, Inc

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Dassault Systèmes

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

Answer : The life science software market size is expected to increase from USD 17.75 billion in 2025 to USD 48.97 billion by 2035.

Answer : The life science software market is expected to grow at a compound annual growth rate (CAGR) of around 10.68% from 2026 to 2035.

Answer : The driving factors of the life science software market are theurgent demand for AI-based automation in drug discovery and even clinical trials to decrease time-to-market and R&D costs.

Answer : North America region will lead the global life science software market during the forecast period 2026 to 2035.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client